Implantable medical constructs formed by winding using winding support structures that can be flexible and can be integrated into the medical construct with biocompatible fiber(s) and/or yarn(s) and at least one continuous length collagen fiber. The implantable medical construct can include open suture anchor apertures formed using posts during a winding sequence.

The invention relates to a compression bandage comprising a first non-woven laser (1) and at least one second non-woven layer (2) connected in a planar manner to the first non-woven layer (1), wherein superabsorbent fibers are provided in the first non-woven laser.

The present disclosure provides a wound dressing composition comprising cross-linked hydrogel scaffold and embedded therein anti-bacterially active honey, said activity being determined by the detection of hydrogen peroxide production rate by said wound dressing; said wound dressing further comprising at least one of a photo-initiator and/or at least one UV cross linker, the total amount of said photo-initiator and/or UV cross linker is equal or less than 0.2% w/w out of the total weight of the wound dressing. Also disclosed herein is a method of preparing the wound dressing and methods of using the same with respect to wounds, the method of preparation comprises mixing a hydrogel forming mixture comprising hydrogel forming monomer or monomers, honey and at least one photo-initiator and/or at least one UV cross-liker to form a homogenous mixture; and subjecting the homogenous mixture to UV irradiation until said homogenous mixture solidifies.

An absorbent component for a wound dressing comprises a stitch bonded nonwoven substrate wherein the nonwoven substrate is stitch bonded with an elastomeric yarn and wherein the nonwoven substrate comprises a superabsorbent material and/or a gelling material. Also disclosed is a method of manufacturing the absorbent component, a wound dressing or a negative pressure apparatus comprising the absorbent component and a method of treating a wound using said wound dressing or negative pressure apparatus comprising the absorbent component.

A dressing for the treatment of incisional wounds includes an upper cover, a patient interface layer, and an absorbent material. The upper cover is configured to substantially cover the incisional wound. The upper cover includes a drape and a plurality of spines coupled to the drape. The drape includes a first side and a second, wound-facing side. The patient interface layer is coupled to the second side of the drape and includes a plurality of openings that are configured to receive fluid from the incisional wound. The absorbent material is disposed between the second side of the drape and the patient interface layer.

The present invention provides thin-film forming compositions comprising an antiseptic (e.g., povidone iodine, chlorhexidine, or octenidine), a non-aqueous solvent, and a film-forming material dissolved in the non-aqueous solvent, wherein the composition yields a continuous and flexible protective film upon substantial removal of the solvent. The compositions are useful for the treatment and prevention of infections in wounds, ulcers (e.g., decubitus ulcers and stasis ulcers), cuts, or burns, or against infections from bacterial, mycobacterial, viral, fungal, or amoeba causes, as well as for prevention of such infections in appropriate clinical settings (e.g., as liquid bandages or dressings). Additionally, the compositions of this invention are also useful for the treatment of infections and as a disinfectant skin preparation for pre- and/or post-surgical operations.

Embodiments disclosed herein are directed to negative pressure treatment systems and wound dressing systems, apparatuses, and methods that may be used for the treatment of wounds. In particular, some embodiments are directed to improved wound dressings comprising a number of viewing portals that facilitate observation of wound tissue or healthy skin underlying the wound dressing. Some embodiments of the viewing portals are provided by forming through holes in internal dressing layers including absorbent material and transmission material, optionally by providing a plug material within the through holes, and by providing translucent or transparent cover layer and tissue contact layer materials.

The present invention relates to a wound dressing composition that is capable of gelling upon contact with a fluid derived from a human or animal body, and which is able to maintain the integrity of the gel for a period of time that is longer than about 24 hours.

An embodiment is an article configured to inhibit or prevent pathogen growth. The article includes an inner layer configured to face a wearer's skin when the face covering article is applied to the face of the wearer; a middle layer adjacent to the inner layer; and an outer protection layer adjacent to the middle layer and opposite the inner layer and comprising a substrate and metal particles in the substrate, wherein the metal particles are configured to inhibit or prevent pathogen growth.

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to bioresorbable hemostatic pads or patches releasably supported on non-resorbable scaffolds for ease of delivery in the field. A sealant and/or hemostat delivery device comprises a resorbable hemostatic pad having a wound facing side and an opposite back side, with a hemostatic and/or wound sealing agent disposed on the wound facing side; a non-resorbable scaffold having an attachment zone on said scaffold; wherein said hemostatic pad is releasably attached with the back side to the attachment zone. The bond between the scaffold and the resorbable hemostatic pad or wound dressing is either (i) severed prior to removal of the scaffold or (ii) is weakened due to the adhesive bonding them together being moisture-deactivated, or (iii) is released by mechanical disentanglement.